Ebosch
ActiveSummary
Ebosch has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €266,925 and a net result of €53,711. Equity is growing by ~23.4% per year across the filed fiscal years. Its solvency ranks better than 42% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability82▼-5
Solvency79▲+1
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €22,000 at 30 days acceptable
Liquidity ample (current ratio 2.75 against 2.98 in 2024; short-term debt: 5.8% and cash: 15.5% of total assets), and 46.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
53.8%
Return on assets
10.8%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
7 d early
2024
1 d early
2023
6 d early
2022
2 d early
2021
32 d early
2020
35 d early
2019
35 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 17 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 28 July (4 of the last 4 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€266,925▲ 13.4%
2024 · €235,321
Total assets
€496,137▲ 11.9%
2024 · €443,356
Net result
€53,711▼ 17.1%
2024 · €64,798
Working capital
€50,314▲ 6.7%
2024 · €47,153
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€68,925▲ 88.2%€32,764▼ 52.5%€78,733▲ 140%€99,148▲ 25.9%€85,431▼ 13.8%
Net result€45,990within the sector's middle half▲ 108%€23,270within the sector's middle half▼ 49.4%€48,185within the sector's middle half▲ 107%€64,798within the sector's middle half▲ 34.5%€53,711within the sector's middle half▼ 17.1%
Equity€131,366within the sector's middle half▲ 51.0%€153,036within the sector's middle half▲ 16.5%€201,221within the sector's middle half▲ 31.5%€235,321within the sector's middle half▲ 16.9%€266,925within the sector's middle half▲ 13.4%
Total assets€144,143below the sector's middle half▲ 33.3%€384,579within the sector's middle half▲ 167%€421,266within the sector's middle half▲ 9.5%€443,356within the sector's middle half▲ 5.2%€496,137within the sector's middle half▲ 11.9%
Debt€12,777▼ 39.7%€231,543▲ 1,712%€220,045▼ 5.0%€208,035▼ 5.5%€229,211▲ 10.2%
Working capital€116,571within the sector's middle half▲ 77.9%€48,514within the sector's middle half▼ 58.4%€72,757within the sector's middle half▲ 50.0%€47,153within the sector's middle half▼ 35.2%€50,314within the sector's middle half▲ 6.7%
Solvency91.1%above the sector's middle half▲ 10.7pp39.8%within the sector's middle half▼ 51.3pp47.8%within the sector's middle half▲ 8.0pp53.1%within the sector's middle half▲ 5.3pp53.8%within the sector's middle half▲ 0.7pp
Current ratio10.12above the sector's middle half▲ 6.033.23within the sector's middle half▼ 6.904.18within the sector's middle half▲ 0.952.98within the sector's middle half▼ 1.202.75within the sector's middle half▼ 0.23
Return on assets (ROA)31.9%above the sector's middle half▲ 11.5pp6.1%below the sector's middle half▼ 25.9pp11.4%within the sector's middle half▲ 5.4pp14.6%within the sector's middle half▲ 3.2pp10.8%within the sector's middle half▼ 3.8pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 14% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €496,137
Fixed assets
€417,074 ▲ 12.0%
Current assets
€79,063 ▲ 11.4%
Equity and liabilities €496,137
Equity
€266,925 ▲ 13.4%
Debt
€229,211 ▲ 10.2%
Debt's share of the balance-sheet total falls from 46.9% to 46.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€105,096▼
2024 · €114,916
Cash flow
€73,376▼
2024 · €80,566
Debt to equity
0.86▼
2024 · 0.88
ROE
20.1%▼
2024 · 27.5%
Interest coverage
15.75▼
2024 · 15.97
Debt ≤ 1 year
€28,749▲
2024 · €23,824
Debt > 1 year
€200,462▲
2024 · €184,211
Income taxes
€25,618▼
2024 · €30,664
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,129 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,129 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €6,672 | €49,442 | €15,877 | €15,768 | €19,665 | ▲ 24.7% |
| Other operating charges640/8 | - | €4,211 | €2,797 | €3,306 | €6,329 | ▲ 91.5% |
| Non-recurring operating charges66A | - | - | €530 | €0 | - | - |
| Gross operating margin9900 | €76,167 | €86,416 | €97,938 | €118,222 | €111,425 | ▼ 5.7% |
| Operating profit (loss)9901 | €68,925 | €32,764 | €78,733 | €99,148 | €85,431 | ▼ 13.8% |
| Financial income75/76B | - | €4,362 | €99 | €3,510 | €570 | ▼ 83.8% |
| Recurring financial income75 | - | €4,362 | €99 | €3,510 | €570 | ▼ 83.8% |
| Financial charges65/66B | - | €2,529 | €7,041 | €7,197 | €6,671 | ▼ 7.3% |
| Recurring financial charges65 | €446 | €2,529 | €7,041 | €7,197 | €6,671 | ▼ 7.3% |
| Profit (loss) for the period before taxes9903 | €68,478 | €34,597 | €71,791 | €95,461 | €79,329 | ▼ 16.9% |
| Income taxes67/77 | €22,488 | €11,326 | €23,606 | €30,664 | €25,618 | ▼ 16.5% |
| Profit (loss) for the period9904 | €45,990 | €23,270 | €48,185 | €64,798 | €53,711 | ▼ 17.1% |
| Profit (loss) for the period to be appropriated9905 | €45,990 | €23,270 | €48,185 | €64,798 | €53,711 | ▼ 17.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €144,143 | €384,579 | €421,266 | €443,356 | €496,137 | ▲ 11.9% |
| Fixed assets21/28 | €14,795 | €314,289 | €325,638 | €372,379 | €417,074 | ▲ 12.0% |
| Tangible fixed assets22/27 | €12,620 | €314,289 | €325,638 | €372,379 | €417,074 | ▲ 12.0% |
| Land and buildings22 | - | €299,633 | €318,342 | €353,823 | €351,819 | ▼ 0.6% |
| Plant, machinery and equipment23 | - | €8,782 | €5,124 | €7,471 | €4,011 | ▼ 46.3% |
| Furniture and vehicles24 | - | €5,343 | €2,172 | €11,086 | €61,244 | ▲ 452% |
| Other tangible fixed assets26 | - | €530 | - | - | - | - |
| Financial fixed assets28 | €2,175 | - | - | - | - | - |
| Current assets29/58 | €129,348 | €70,290 | €95,628 | €70,977 | €79,063 | ▲ 11.4% |
| Amounts receivable within one year40/41 | €602 | €13,674 | €13,775 | €0 | €2,053 | - |
| Trade receivables40 | - | - | €101 | €0 | - | - |
| Other amounts receivable41 | - | €13,674 | €13,674 | €0 | €2,053 | - |
| Current investments50/53 | €16,195 | €16,195 | €16,195 | €0 | - | - |
| Cash at bank and in hand54/58 | €112,551 | €40,422 | €65,658 | €70,977 | €77,010 | ▲ 8.5% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €144,143 | €384,579 | €421,266 | €443,356 | €496,137 | ▲ 11.9% |
| Equity10/15 | €131,366 | €153,036 | €201,221 | €235,321 | €266,925 | ▲ 13.4% |
| Contributions10/11 | - | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €125,166 | €146,836 | €195,021 | €229,121 | €260,725 | ▲ 13.8% |
| Tax-exempt reserves132 | - | €23,482 | €23,482 | €23,482 | €23,482 | = |
| Distributable reserves133 | - | €123,354 | €171,539 | €205,639 | €237,243 | ▲ 15.4% |
| Profit (loss) carried forward14 | - | - | - | €0 | €0 | - |
| Amounts payable17/49 | €12,777 | €231,543 | €220,045 | €208,035 | €229,211 | ▲ 10.2% |
| Amounts payable after more than one year17 | - | €209,766 | €197,174 | €184,211 | €200,462 | ▲ 8.8% |
| Financial debts170/4 | - | €209,766 | €197,174 | €184,211 | €200,462 | ▲ 8.8% |
| Amounts payable within one year42/48 | €12,777 | €21,777 | €22,870 | €23,824 | €28,749 | ▲ 20.7% |
| Current portion of amounts payable after more than one year42 | - | €12,231 | €12,592 | €12,963 | €22,168 | ▲ 71.0% |
| Trade debts44 | €55 | - | - | €8 | €0 | ▼ 100% |
| Suppliers440/4 | - | - | - | €8 | €0 | ▼ 100% |
| Taxes, remuneration and social security45 | - | €146 | €1,730 | €3,809 | €148 | ▼ 96.1% |
| Taxes450/3 | - | €146 | €1,730 | €3,809 | €148 | ▼ 96.1% |
| Other amounts payable47/48 | - | €9,400 | €8,548 | €7,043 | €6,432 | ▼ 8.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €45,990 | €23,270 | €48,185 | €64,798 | €53,711 | ▼ 17.1% |
| + Depreciation and write-downs630 | €6,672 | €49,442 | €15,877 | €15,768 | €19,665 | ▲ 24.7% |
| Operating cash flow (approximation) | €52,662 | €72,712 | €64,062 | €80,566 | €73,376 | ▼ 8.9% |
| Investment in fixed assets (approximation) | - | -€348,936 | -€27,227 | -€62,509 | -€64,360 | ▼ 3.0% |
| Change in cash | - | -€72,129 | €25,236 | €5,319 | €6,033 | ▲ 13.4% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €64,798 ▲34.5%
Operating result €99,148, net result €64,798, both a record.
25-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €200,000Eq €201,221 ▲31.5%
6 profitable years in a row build equity to €201,221.
29-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €150,000Eq €153,036 ▲16.5%
5 profitable years in a row build equity to €153,036.
29-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-09
Financial
Liquidity doublescurrent ratio 10.12
Current ratio from 4.09 to 10.12; short-term debt falls from €21,198 to €12,777.
30-09
Financial
Equity above €100,000Eq €131,366 ▲51%
4 profitable years in a row build equity to €131,366.
26-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
26-03
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Show earlier events
2019
26-03
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
10-04
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
29-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 4 acts read
About the unread acts
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beveren-Kruibeke-Zwijndrecht · 1 establishment unit since 1999
Ground area
1,612 m²
Building footprint
194 m²
Volume, LiDAR
1,228 m³
Parcel 46001B0033/00B000, Flanders · tallest building 10.1 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Ebosch
since 19992.216.653.007
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46001B0033/00B000 | Flanders | 1,612 m² | 1 · 194 m² | 10.1 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 405 EUR awarded · 405 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 405 EUR | 405 EUR |
Similar companies · same sector, comparable size
STRYPSTEIN MEDICAL
BE 0888.068.058
Liège · Eq €267,048
CABINET D'ORTHOPEDIE STAINIER
BE 0464.304.158
Lobbes · Eq €267,067
Dr. Mieke Tack
BE 0667.861.331
Rotselaar · Eq €267,080
DOCTEUR SOPHIE ANRIJS PNEUMOLOGIE SPRL
BE 0847.977.859
Chaumont-Gistoux · Eq €267,209
Dr.DHM
BE 0755.562.989
Rotselaar · Eq €267,248
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 6,686 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded23-11-1999
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0467582263
Also
9925:BE0467582263
Registered
06-01-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.